Samlyn Capital, LLC Eliem Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

  • $6.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.77 - $8.4 $5.9 Million - $17.9 Million
-2,130,237 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$8.01 - $13.15 $3.42 Million - $5.61 Million
426,691 Added 25.05%
2,130,237 $17.9 Million
Q4 2021

Feb 14, 2022
BUY
$8.61 - $20.47 $193,905 - $461,004
22,521 Added 1.34%
1,703,546 $17.8 Million
Q3 2021

Nov 15, 2021
BUY
$14.45 - $28.61 $24.3 Million - $48.1 Million
1,681,025 New
1,681,025 $30.2 Million

Others Institutions Holding ELYM

# of Institutions
69
Shares Held
53.1M
Call Options Held
0
Put Options Held
0
View Full List

About Eliem Therapeutics, Inc.

ELYM Quotes by TradingView
  • Ticker ELYM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,567,700
  • Market Cap $109M
  • Description
  • Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...
More about ELYM
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email